Pearl Therapeutics Garners $15,000,000 Series C Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e8763377-5eb4-46f9-a181-9de3677a5fc6&Preview=1 -
Date
2/1/2010 -
Company Name
Pearl Therapeutics -
Mailing Address
200 Saginaw Drive Redwood City, CA 94063 -
Company Description
Pearl Therapeutics is focused on developing a pipeline of novel and
superior products for chronic respiratory disorders, providing patients
with advanced therapeutic options in familiar and well accepted dosage
forms. The company has licensed advanced particle technology from Nektar
Therapeutics (Nasdaq: NKTR) for developing a series of products in selected
therapeutic fields. -
Website
http://www.pearltherapeutics.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,000,000 -
Transaction Round
Series C -
Proceeds Purposes
We anticipate that this capital infusion and our planned Series C financing will provide us with sufficient funds to advance PT003 through all of the Phase 2b trials necessary to initiate the Phase 3 program. -
M&A Terms
-
Venture Investor
Clarus Ventures -
Venture Investor
New Leaf Venture Partners -
Venture Investor
5AM Ventures
